OTCMKTS:BITGF

Biotage AB (publ) (BITGF) Stock Price, News & Analysis

$14.63
0.00 (0.00%)
(As of 04/30/2024 ET)
Today's Range
$14.63
$14.63
50-Day Range
$14.63
$16.87
52-Week Range
$8.00
$16.87
Volume
N/A
Average Volume
233 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
BITGF stock logo

About Biotage AB (publ) Stock (OTCMKTS:BITGF)

Biotage AB (publ) provides solutions and products in the areas of drug discovery and development, analytical testing, and water and environmental testing. The company offers organic and peptide synthesis solutions; flash chromotherapy, evaporation, and work-up products; flash systems; sample preparation products; plasmid purification solutions; oligo synthesis solutions; and metal scavengers and reagents, as well as accessories and spare parts. It also provides sample preparation solutions in the clinical and bioanalytical, forensic and toxicology, doping control animal and human, environment, and food and agriculture areas, as well as consumables and systems; protein purification solutions, including antibody and tagged proteins purification, automation systems, and custom packing service, as well as ion exchange, reversed phase, normal phase, and gel filtration PhyTip columns. The company sells its products to pharmaceutical and biotechnical companies, contract research and manufacturing organizations, diagnostics, clinical, environmental protection, food safety, clinical, forensic, and academic laboratories industries. It operates in more than 80 countries, which include Americas, Europe, the Middle East, Africa, and Asia Pacific. Biotage AB (publ) was founded in 1969 and is headquartered in Uppsala, Sweden.

BITGF Stock Price History

BITGF Stock News Headlines

Biotage AB (publ) (OTCMKTS:BITGF) Stock Price Down 13.3%
EVGGF Evolution AB (publ)
Trump’s last act as President
You’ve probably never heard of Executive Order #13972. Signed by President Trump just days before leaving office, it greenlit what could be the most revolutionary technology of the decade… yet it has nothing to do with AI, blockchain, or mRNA vaccines.
ZINZINO AB (PUBL): PRELIMINARY SALES REPORT APRIL 2023
Vimian Group AB (publ) reports Q1 results
Biotage AB
Biotage AB (publ) (BIOT.ST)
Trump’s last act as President
You’ve probably never heard of Executive Order #13972. Signed by President Trump just days before leaving office, it greenlit what could be the most revolutionary technology of the decade… yet it has nothing to do with AI, blockchain, or mRNA vaccines.
CMO to leave HMS Networks AB (publ)
Lifco publ AB (LIFCOb)
Biotage AB (publ) publishes new Financial Goals
BITGF After-Hours Quotes
Biotage Awarded Gold Sustainability Medal by EcoVadis
Biotage AB (publ) Year-end report January - December 2021
Biotage moves to the large cap segment
Change in number of shares and votes
Biotage - Change in number of shares and votes
Biotage AB (publ) Interim report January - September 2021
Biotage A earnings preview: what Wall Street is expecting
Biotage appoints Nomination Committee
See More Headlines
Receive BITGF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Biotage AB (publ) and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Medical Instruments & Supplies
Sub-Industry
N/A
Current Symbol
OTCMKTS:BITGF
CIK
N/A
Fax
N/A
Employees
669
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Key Executives

  • Mr. Torben Jorgensen B.Sc. (Age 72)
    CEO, President & Director
    Comp: $857k
  • Mr. Andrew Kellett (Age 55)
    Chief Financial Officer
  • Mr. Anders Wikstrom BSc (Age 51)
    CS, Executive Vice President of Operations
  • Raffaella Bombarda (Age 50)
    EVP of Global Marketing
  • Ms. Petra Duprez (Age 59)
    Chief Human Resources & Sustainability Officer
  • Mr. Scott Carr (Age 57)
    President of Americas & Chief/Head of Americas
  • Mr. Jonas Stahlberg (Age 49)
    Chief Auditor
  • Mr. Olof Nord (Age 49)
    Executive Vice President of Business Development
  • Mr. Andreas Juhlin (Age 50)
    President of International - EMEA and APAC
  • Mr. Magnus Nordstedt (Age 54)
    Executive Vice President of IT & Digitalization

BITGF Stock Analysis - Frequently Asked Questions

Should I buy or sell Biotage AB (publ) stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Biotage AB (publ) in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" BITGF shares.
View BITGF analyst ratings
or view top-rated stocks.

How have BITGF shares performed in 2024?

Biotage AB (publ)'s stock was trading at $12.00 at the beginning of the year. Since then, BITGF stock has increased by 21.9% and is now trading at $14.63.
View the best growth stocks for 2024 here
.

How do I buy shares of Biotage AB (publ)?

Shares of BITGF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:BITGF) was last updated on 5/1/2024 by MarketBeat.com Staff

From Our Partners